Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 11 2018
accepted: 08 02 2019
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 26 11 2019
Statut: epublish

Résumé

New immigrants to Canada with a history of tuberculosis or evidence of old healed tuberculosis on chest radiograph are referred to public health authorities for medical surveillance. This ostensible public health protection measure identifies a subgroup of patients (referrals) who are at very low risk (compared to non-referrals) of transmission. To assess whether earlier diagnosis or a different phenotypic expression of disease explains this difference, we systematically reconstructed the immigration and transmission histories from a well-defined cohort of recently-arrived referral and non-referral pulmonary tuberculosis cases in Canada. Incident case chest radiographs in all cases and sequential past radiographs in referrals were re-read by three experts. Change in disease severity from pre-immigration radiograph to incident radiograph was the primary, and transmission of tuberculosis, the secondary, outcome. There were 174 cohort cases; 61 (35.1%) referrals and 113 (64.9%) non-referrals. Compared to non-referrals, referrals were less likely to be symptomatic (26% vs. 80%), smear-positive (15% vs. 50%), or to have cavitation (0% vs. 35%) or extensive disease (15% vs. 59%) on chest radiograph. After adjustment for referral status, time between films, country-of-birth, age and co-morbidities, referrals were less likely to have substantial changes on chest radiograph; OR 0.058 (95% CI 0.018-0.199). All secondary cases and 82% of tuberculin skin test conversions occurred in contacts of non-referrals. Phenotypically different disease, and not earlier diagnosis, explains the difference in transmission risk between referrals and non-referrals. Screening, and treating high-risk non-referrals for latent tuberculosis is necessary to eliminate tuberculosis in Canada.

Sections du résumé

BACKGROUND
New immigrants to Canada with a history of tuberculosis or evidence of old healed tuberculosis on chest radiograph are referred to public health authorities for medical surveillance. This ostensible public health protection measure identifies a subgroup of patients (referrals) who are at very low risk (compared to non-referrals) of transmission.
METHODS
To assess whether earlier diagnosis or a different phenotypic expression of disease explains this difference, we systematically reconstructed the immigration and transmission histories from a well-defined cohort of recently-arrived referral and non-referral pulmonary tuberculosis cases in Canada. Incident case chest radiographs in all cases and sequential past radiographs in referrals were re-read by three experts. Change in disease severity from pre-immigration radiograph to incident radiograph was the primary, and transmission of tuberculosis, the secondary, outcome.
RESULTS
There were 174 cohort cases; 61 (35.1%) referrals and 113 (64.9%) non-referrals. Compared to non-referrals, referrals were less likely to be symptomatic (26% vs. 80%), smear-positive (15% vs. 50%), or to have cavitation (0% vs. 35%) or extensive disease (15% vs. 59%) on chest radiograph. After adjustment for referral status, time between films, country-of-birth, age and co-morbidities, referrals were less likely to have substantial changes on chest radiograph; OR 0.058 (95% CI 0.018-0.199). All secondary cases and 82% of tuberculin skin test conversions occurred in contacts of non-referrals.
CONCLUSIONS
Phenotypically different disease, and not earlier diagnosis, explains the difference in transmission risk between referrals and non-referrals. Screening, and treating high-risk non-referrals for latent tuberculosis is necessary to eliminate tuberculosis in Canada.

Identifiants

pubmed: 30849130
doi: 10.1371/journal.pone.0212706
pii: PONE-D-18-34221
pmc: PMC6407769
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212706

Subventions

Organisme : CIHR
ID : 125961
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Microbiol. 1993 Feb;31(2):406-9
pubmed: 8381814
PLoS One. 2015 Dec 23;10(12):e0144784
pubmed: 26700163
Lancet. 2016 Nov 19;388(10059):2510-2518
pubmed: 27742165
CMAJ. 2018 Feb 26;190(8):E209-E216
pubmed: 29483329
CMAJ. 2015 Nov 3;187(16):E473-E481
pubmed: 26416993
Lancet Public Health. 2017 Oct;2(10):e450-e457
pubmed: 29253429
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130437
pubmed: 24821923
Sci Transl Med. 2013 Nov 27;5(213):213sr6
pubmed: 24285487
BMC Med. 2016 Mar 23;14:48
pubmed: 27004556
Eur Respir J. 2016 Jul;48(1):274-6
pubmed: 27365510
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1044-52
pubmed: 25265362
Am J Respir Crit Care Med. 2000 Nov;162(5):1738-40
pubmed: 11069805
Lancet Infect Dis. 2018 Oct;18(10):1077-1087
pubmed: 30174209
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637
pubmed: 28482956
Expert Rev Anti Infect Ther. 2013 Feb;11(2):137-46
pubmed: 23409820
Int J Tuberc Lung Dis. 2002 Feb;6(2):121-9
pubmed: 11931410
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1000-1006
pubmed: 30092864
Int J Tuberc Lung Dis. 2004 Apr;8(4):392-402
pubmed: 15141729
Am Rev Respir Dis. 1985 Mar;131(3):393-6
pubmed: 3977176
Int J Tuberc Lung Dis. 2002 Jul;6(7):615-21
pubmed: 12102301
Chest. 1991 Jan;99(1):123-7
pubmed: 1984941
Tubercle. 1991 Dec;72(4):277-83
pubmed: 1811359
Chest. 1999 Oct;116(4):961-7
pubmed: 10531160
J Clin Microbiol. 2006 Dec;44(12):4498-510
pubmed: 17005759
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
Int J Tuberc Lung Dis. 2001 Mar;5(3):216-9
pubmed: 11326819
Chest. 1994 Jul;106(1):326
pubmed: 8020312
J Clin Microbiol. 1993 Jul;31(7):1677-82
pubmed: 8102372
Lancet Infect Dis. 2017 Jul;17(7):770-779
pubmed: 28410979
PLoS One. 2016 Apr 22;11(4):e0154032
pubmed: 27105337

Auteurs

Richard Long (R)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Leyla Asadi (L)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Courtney Heffernan (C)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

James Barrie (J)

Department of Radiology and Diagnostic Imaging, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Christopher Winter (C)

Department of Radiology and Diagnostic Imaging, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Mary Lou Egedahl (ML)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Catherine Paulsen (C)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Brenden Kunimoto (B)

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Dick Menzies (D)

Montreal Chest Institute, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH